Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Integrin alphaXbeta2 MeSH Descriptor Data 2025


MeSH Heading
Integrin alphaXbeta2
Tree Number(s)
D09.400.430.890.200.275
D12.776.395.550.200.275
D12.776.543.550.200.275
D12.776.543.750.705.408.600.100
D12.776.543.750.705.833.249
D23.050.301.350.275
Unique ID
D016167
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016167
Scope Note
A major adhesion-associated heterodimer molecule expressed by MONOCYTES; GRANULOCYTES; NK CELLS; and some LYMPHOCYTES. The alpha subunit is the CD11C ANTIGEN, a surface antigen expressed on some myeloid cells. The beta subunit is the CD18 ANTIGEN.
Entry Term(s)
Antigen p150,95
CR4 Receptor
Complement Receptor 4
Complement Receptor Type 4
Leukocyte Adhesion Protein p150,95
Neutrophil GP150
Neutrophil Glycoprotein Gp150
Receptor, CR4
alphaXbeta2 Integrin
p150,95 Antigen
p150,95 Glycoprotein
Registry Numbers
0
Previous Indexing
Antigens, Differentiation (1988-1990)
Receptors, Leukocyte-Adhesion (1989-1990)
Public MeSH Note
2003; see COMPLEMENT 4-BINDING PROTEIN 2002, see ANTIGEN P150,95 1991-2001; INTEGRIN APHAXBETA2 was indexed under MEMBRANE GLYCOPROTEINS 1988-2002 & GLYCOPROTEINS 1985-1987
History Note
2003 (1991); use INTEGRIN ALPHAXBETA2 (NM) 1985-2002
Date Established
1991/01/01
Date of Entry
1990/04/24
Revision Date
2023/03/16
Integrin alphaXbeta2 Preferred
page delivered in 0.134s